Effective results driven research requires a critical mass of expertise and state-of-the-art infrastructure for the Australian life sciences sector. Through the National Collaborative Research Infrastructure Strategy (NCRIS) federal government investment, Australia ensures highly skilled researchers have access to world-class technology platforms and translation.
Therapeutic Innovation Australia, Bioplatforms Australia and Phenomics Australia are enabled by NCRIS and are members of the NCRIS Health Group that work with both academic and industry researchers.
Strategic expansion of Australia’s translational and therapeutic drug discovery and development capabilities via the members of the NCRIS Health Group, can unlock the health and financial benefits contained within Australia’s ground-breaking medical research discoveries by opening up potential collaboration opportunities with international enterprises.